I think the thanking of trial patients is from lea
Post# of 145268
![](/assets/46931549/no_avatar_available_thumb.jpg)
The SP reaction again proves that this company is reguarded as a "throw what ever indecation against the wall and see what sticks" biotech. All the proof that this drug works as an HIV drug has been a back seat to the seemingly desperate new indications that pop up at an unheard of pace. Until they have a major partner putting a foundation under this and the BLA filed we don't look any different no mater the # or type of indication potential (as we have all been repeating).
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)